Courts Rule Against Samsung and Guardant Health in Patent Cases
International and U.S. courts have issued separate patent infringement rulings, ordering Samsung to pay Swatch $11.6 million for copying smartwatch applications and directing Guardant Health to pay $245 million for infringing cancer diagnostic patents. The decisions highlight ongoing legal battles over intellectual property in technology and healthcare.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Samsung must pay Swatch $11.6mn over copycat smartwatch apps
Swiss watchmaker had sought damages of as much as $170mn in London lawsuit over copyright infringement
Read full article →US court orders Guardant Health to pay $245 million for cancer patent infringement
A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology. Guardant Health will pay an upfront amount and an ongoing royalty until March 2033. The company announced it will appeal the final judgment and is confident in its position.
By TOI TECH DESK
Read full article →
